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Abstract Despite technological advances, the mortality
rate for critically ill oldest old patients remains high. The
intensive caring should be able to combine technology and
a deep humanity considering that the patients are living the
last part of their lives. In addition to the traditional goals of
ICU of reducing morbidity and mortality, of maintaining
organ functions and restoring health, caring for seriously
oldest old patients should take into account their end-of-life
preferences, the advance or proxy directives if available,
the prognosis, the communication, their life expectancy
and the impact of multimorbidity. The aim of this review
was to focus on all these aspects with an emphasis on some
intensive procedures such as mechanical ventilation, non-
invasive mechanical ventilation, cardiopulmonary resusci-
tation, renal replacement therapy, hemodynamic support,
evaluation of delirium and malnutrition in this heteroge-
neous frail ICU population.
Keywords Oldest old  Critical care  Intensive geriatric
care
Introduction
According to an international convention, oldest old def-
inition identifies a demographic group of people aged 85
and over [1]. Over the past decades, the oldest olds were
the most rapidly expanding segment of the population in
developed countries [2] thanks to the mortality rate
reduction [3], the improvements in economic and social
conditions and to the ongoing medical advances [4].
However, the oldest old age group represents only a small
proportion of the total population, and in clinical studies it
is often considered as a part of a wider age group as that of
65 and over, 75 and over [5] or 80 and over [6]. People
aged 85 and over cannot be considered a homogeneous
population. They may experience multiple chronic condi-
tions simultaneously as well as some specific and non-
communicable diseases as memory loss, urinary
incontinence, depression and falls or immobility which are
the major causes of disability and health problems [7]. The
prevalence of multimorbidity increases in the subjects aged
more than 80 up to 78 % [8]. The multimorbidity is asso-
ciated with a higher mortality [9], to the disability and to a
higher health care utilization [10]. Oldest old people are
frailer, often ill and more dependent than younger old
people. These characteristics influence strongly the deci-
sion for the intensive care unit (ICU) admission. The
advanced age, the comorbidity, the disability, the burden of
chronic conditions, the life expectancy are all factors that
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the physicians considered to be clinically relevant on the
older critically ill patients’ outcome [11]. Currently many
clinical trials, national and international surveys, do not
provide sufficient data for evidence-based caring for criti-
cally ill oldest old patients. The majority of the investiga-
tions are retrospectives studies, and their data are not
homogeneous. The tendency for very old patients to
receive less intensive treatment [12] represents an evident
bias in reporting data practice. The selection process from
emergency room to the ICU admission renders the oldest
old patients in these studies poor representatives of the
entire population of critically ill older patients [13]. The
aim of this review is to focus on some significant factors
which influence the caring for critically ill oldest old
patients in daily practice.
The life expectancy evaluation
Taking into account in everyday practice life expectancy,
especially of the older patient, it is essential to identify
those patients with longer life expectancy, because poten-
tially these patients will more likely benefit from aggres-
sive treatment versus those that are more vulnerable to
adverse outcome [14]. The awareness of life expectancy
allows to understand more appropriately the preferences of
the patients and the possible outcome; furthermore the age
must not be the most important factor to decide the ICU
admission of the older patients [15]. In 2010 in the USA,
life expectancy at the age of 65 rose to 19.1 and the average
time to live for a person turning 85 was 6.5 years. Life
expectancy by age and all races and origin was 4.6 at the
age of 90, 3.5 at the age of 95 and 2.3 years at the age of
100 [16]. Similar trends have been observed in almost all
developed nations. The Italian resident population aged
more than 85, on January 1, 2015 was 1,930,039 for an
amount of 3.18 % of the total resident population. In Italy,
life expectancy for oldest old increased over the last
40 years (Fig. 1). Currently those people aged 85 are
expected to live 91 years for male and 92.1 for female,
while those aged 90 are expected to live, respectively,
94.2 years and 94.8 years. At the age of 95, life expectancy
is 97.9 for male and 98.1 for female, while at the age of
100, it is 102 for male and 102.1 for female. At the age of
105, life expectancy is 106.2 [17].
Oldest old end-of-life treatment preferences
During a severe acute illness, the oldest old patients, even
when they are competent, are often unable to express their
wishes [18]. The severity of the patients’ conditions, poor
level of education and male gender are the predictors for a
passive role in the doctor–patient relationship [19]. Older
patients often prefer to defer the decision about intensive
cares to others. They frequently prefer that the physicians
have the greater input in decision-making process
[20, 21]. The self-reported preferences for treatments are
influenced mostly by their personal values, religion and
by experiences with illnesses [22]. Fried et al. [23]
showed that the burden of treatment and its outcomes
were strong determinants of older seriously ill patients’
preferences. For example, in case of low burden treatment
with the outcomes of severe cognitive and/or functional
impairment, the majority of older patients would have
chosen not to receive the therapy. On the other hand in the
case of high burden of treatment with the return to their
current health, the majority of them accepted the treat-
ment. Although in this study, the patients had advanced
stages of illness, the perception of their life expectancy
suggested that they did not consider themselves to be
close to death. Furthermore, over the time, seriously ill
older patients retain great diversity in their willingness to
endure burdensome therapy or risk of severe disability to
avoid death [24]. Other determinant on the critically ill
older patients’ preferences is the awareness of medical
practice. Recently Wilson et al. [25] showed that the use
of a video depicting cardiopulmonary resuscitation and
explaining resuscitation preference options was consid-
ered helpful in decision making by patients and surro-
gates. Independent IADL and ADL older patients were
interviewed after the viewing of some videos which
described the use of noninvasive mechanical ventilation
(NIV), invasive mechanical ventilation and renal
replacement therapy (RRT) after a period of IMV. These
patients, after this viewing, showed great reluctance to
accept life-sustaining treatments, especially IMV and
RRT. Retaining their quality of life was the determinant
associated with this choice [26].
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Legal issues and advance directives
The decision making for critically oldest old patients is
often dependent on the context, and it is made by an
agreement between family and clinicians. Furthermore the
decision for the life-sustaining treatment and ICU admis-
sion is often made when the clinic condition suddenly gets
worse and/or the patient is unconscious. The informed
consent process still applies unreservedly to older patients.
Old age and frailty should be not considered factors which
may inhibit ones’ decisional capability. In this context,
physicians deal with three different situations on a daily
basis: (1) patients with good cognitive functioning; (2)
patients with various degrees of cognitive impairment; and
(3) patients with a legal guardian [27]. In the first case,
physicians should give information and recall consent by
removing communication barriers (sensorial deficits, low
education level, different language, presence of pain and
mood disorders, impaired ability to communicate, limited
independency, illiterate conditions) for a competent deci-
sion. This is the case of critically ill older patients con-
sidered competent and capable of choice [28]. In the
second case, if there are depression and mild cognitive
impairment or early dementia, psychiatric consultation
should be taken into account, although these conditions do
not preclude the patient’s ability to make a competent
decision [29]. The assessment of competency should
include a clinical and diagnostic interview, a neuropsy-
chological testing and a functional ability assessment [30].
In the third case, the tutor or legal guardian has the duty to
sign the informed consent form. If a patient is incompetent,
the need for an appropriate surrogate decision maker will
be required. The legal procedures of surrogate decision-
making process include advanced directives, legal guar-
dians and family members in a hierarchy that varies from
state to state. In many nations, the decisional power is
given to the relatives, the proxy and to the surrogate
(Table 1). In Italy, there are no specific legal regulations
about the role of formal advanced directives in medical
treatment, as well as the right of a person to designate a
proxy for medical decisions. The Italian law, January 9,
2004, n. 6 stated that no decision-making right is
acknowledged to family members unless they are legal
delegates [31]. The adoption of advanced directives was
the first formal response to many critical deficits which
made the medical care of dying patients painful [32],
expensive [33, 34], and emotionally burdensome to both
patients and their families [35]; the comfort care prefer-
ences were subverted [36]. In the case of emergency care
or any life-saving treatment, Italian law does not require
patient consent to undergo treatment. It must be
documented in the medical records by the physician that
the procedure used was urgent and essential [27].
Ventilatory strategy in critically ill oldest old
patients
Mechanical ventilation (MV)
In an emergency scenario, if a severe respiratory failure
threatening the oldest old patient’s life functions occurs,
beyond the advanced or proxy directives, informed consent
to intubation is not required. It is, however, essential to
inform the patient (and family members) about his/her
serious illness, about the need of MV and about the
admission to ICU. In the clinical practice, many physicians
are reluctant to use MV and ICU admission in oldest old
patients even when the criteria are appropriate [37]. The
MV use decreased significantly with advanced age even
after adjustment for DNR (do not resuscitate) status [38].
There are some main reasons behind this practice. The first
reason concerns the poor prognosis and the subsequent
belief that MV and ICU care could be deleterious. Sec-
ondly this practice may not actually be what the patient or
the family wants [39]. Other physicians consider the MV a
questionable option in some daily (do not intubate) DNI-
related clinical scenarios, for example in an oldest old
patient, bedridden, dependent in daily activity, with mul-
timorbidity and with acute respiratory failure [40]. The
impact of age on survival after intensive care has been
known for a long time. Cohen et al. [41] in 1995 assessed
the dramatic impact of age on outcome from mechanical
ventilation using a population of 41,848 patients from
statewide database. For the patients aged between 85 and
89 (n = 3145), the mortality rate was 67 % and for the
patients aged 90 or more (n = 1812) the mortality rate
reached to 75 %. The mortality rate for oldest old patients
admitted to ICU who did not receive mechanical ventila-
tion was 22 and 26 %, respectively. The inverse relation-
ship between survival and age with the lower survival rate
for patients aged between 85 and 89 and 90 or more
undergoing mechanical ventilation (38 percent and 30
percent, respectively) was assessed by Kurek in 1998 [42].
Mortality in older patients has been the subject of numer-
ous investigations. Figure 2 showed clearly that mechani-
cal ventilation is a strong predictive factor of mortality in
very seriously ill oldest old patients [41, 43–50]. In a
multicenter, prospective cohort study [51] including
patients with the average age of 85 (n:1671), one third of
very old patients died in hospital (n 289) while receiving
mechanical ventilation, vasopressors or dialysis. In this
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study, the presence of frailty or advanced directived had
little impact on limiting use of sustaining treatments or
shortening the time from admission to death. The rela-
tionship between mechanical ventilation and low or intense
associated treatment, using, respectively, noninvasive
ventilation or invasive ventilation with low or high end
expiratory support (PEEP) plus vasopressors agents was
recently studied by Peigne et al. [52]. Hospital mortality
significantly increased with age in all treatment groups and
patients with age[80 years showed higher mortality rate
independently of intense treatment group. Some authors
reported that age had no influence on mortality rate
between the younger and the older age group. They found
that the only factor showing a significant influence on older
patient outcome was the reason for mechanical ventilation,
ventilatory versus hypoxemic respiratory failure [53]. A
randomized, controlled trial conducted by Ely et al. in 2002
[54] examined age as independent risk factor in recovery
and ICU discharge after acute respiratory distress syn-
drome (ARDS). The 28-day survival was greater in the
group of younger patients (\70 years of age) than in older
patients. Older age was a strong predictor of in-hospital
death. The main finding in this study was that older sur-
vivor had greater difficulty achieving liberation from the
ventilator and being discharged from the ICU. Mortality
rate in patients with ARDS increased with age reaching 60
percent for patients aged 85 or older [55]. The ARDSNet
trial [56] showed that the gold standard treatment was a Vt
of 6 ml/Kg calculated on the basis of predicted body
weight and using volume controlled ventilation. The
authors stated that high frequency ventilation was the ideal
way of ventilating patients with ARDS such as a higher
level of PEEP, the prone position and the recruitment
maneuvers. Sutherasan et al. [57] showed that in patients at
risk of ARDS but without previously noninjured lung, the
implementation of protective ventilator strategies, consist-
ing of VT of 6 ml/kg, PEEP of 6–12 cm H2O and recruit-
ment maneuvers can decrease the development of ARDS,
pulmonary infection and atelectasis but not mortality.
Eachempati et al. [58] observed that for the older patients
of a ‘‘pure’’ ARDS population, the use of a low VT strategy
Table 1 Summary about legislation in different country for incompetent patients
Incompetent patients Advance directive of treatment
Austria Decisional power of a relative Validity of living will and power of attorney
Belgium Decisional power of a relative Validity of living will and power of attorney
Bulgaria Decisional power of the closest relative No legal availability of living will and power
of attorney
Denmark Decisional power of the closest relative or friend Validity of living will and power of attorney
Finland Consultative role of relatives Still debating
France Consultative role of relatives Consultative role
Germany Validity of designed surrogate. In lack of this consultative role of relatives Validity of living will and power of attorney
Hungary Decisional power to proxy Validity of living will and power of attorney
Italy No possibility for patients to appoint a surrogate. Only a judge may appoint a
support administrator
No legal availability of living will and power
of attorney
The
Netherland
Consultative role of relatives Validity of living will and power of attorney
Norway Consultative role of proxy Still debating
Spain Decisional power of a relative Validity of living will and power of attorney
Switzerland Decisional power of a surrogate Validity of living will and power of attorney
Turkey Still debating Still debating
UK Decisional power of a surrogate Validity of living will and power of attorney
USA Decisional power of a surrogate Validity of living will and power of attorney
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Fig. 2 Odds ratio risk for oldest old patients undergoing to mechan-
ical ventilation in overall oldest old ICU population
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failed to show a marked benefit. The benefit of prolonged
mechanical ventilation (for more than 29 days) showed a
mortality rate in older patients of 45 % percent while in the
younger patients was of 30 % [59]. Prolonged mechanical
ventilation was considered one of the most important fac-
tors for tracheostomy rate. Age-adjusted incidence of tra-
cheostomy increased by 106 %, rising disproportionately
to mechanical ventilation use [60]. Although tracheostomy
is a safe surgical procedure in the oldest old patients, the
rate of the postoperative mortality was high. The rate
reached 75 % within three postoperative months and to 93,
8 within the first year [61]. Tracheotomies are routinely
performed for severely ill and elderly patients with respi-
ratory failure. However, mortality rate was high after tra-
cheotomy both in ICU and after discharge [62].
Noninvasive mechanical ventilation (NIMV)
in oldest old patients
The choice of noninvasive mechanical ventilation (NIMV)
aims to avoid complications in fragile and older patients
[12]. Indications for NIMV treatment in older patients did
not differ from the younger patients. NIMV, within both
the ICU and the ward environment, has reduced intubation
rate and mortality in COPD patients with decompensated
respiratory acidosis following immediate medical therapy,
as shown in RCTs and in many systematic reviews [63].
Age does not imply a poorer response. Chandra in his study
[64] reported data about NIMV outcome in acute exacer-
bations of chronic obstructive pulmonary disease during
years 1998–2008. In this study, 12,499 oldest old patients
were treated initially with NIV, and 24,359 were initially
treated with invasive mechanical ventilation (IMV]. The
mortality rate was higher in IMV group (n:
9167 = 37.7 %) than in NIMV group (n: 1220 = 9.7 %).
A small proportion of oldest old patients transitioned from
NIMV to IMV (n: 664) with an increased mortality rate
(n:79 = 12 %). In the study by Shortgen et al. [65], very
old patients managed using NIMV have an overall satis-
factory 6-month survival and functional status, except for
endotracheal intubation after NIMV failure. Segrelles et al.
[66] compared the results in older patients with those
obtained in younger patient group. There were no differ-
ences in terms of in-hospital mortality between the two
groups. However, this population was more frequently
readmitted within 6–12 months after hospital discharge
than the younger. In oldest old population, NIMV can be
considered as a good alternative for treating respiratory
acidosis even for those with a do not intubate order (DNI),
defined by the unfavorable balance for intubation expres-
sed by the emergency department physician (on the basis of
advanced age and bad clinical status) and consultation with
patients and his/her relatives, with a satisfactory long-term
survival, especially when they continue NIMV at home
[67]. Refusing ICU admission is common among older
patients, especially for those with acute respiratory failure
and cancer. The prognosis was influenced by the underly-
ing cause of respiratory failure, efficiency of cough and
mental status and by initial selection of patients [68].
Furthermore, the use of NIV as a palliative treatment for
respiratory failure and dyspnea has become increasingly
common [69]. NIMV could be worthwhile for older
patients where invasive ventilation is not considered as an
option, either because invasive ventilation is against the
patient’s wish or because NIMV is considered the limit as a
part of end-life-decision. In this context the results in the
Bulow’s study [70] a 25 % of survival rate to hospital
discharge and a 10 % after 5-year among older DNI
patients were significant. Palliative NIMV is regularly
performed in the ICU as in the medical wards and the
emergency department. In the study by Vargas and col-
leagues [71], very old patients with DNI order were stud-
ied. They treated these patients with NIMV in a half-open-
geriatric ward with trained physicians and nurses. After
12 h of NIMV in the geriatric ward, 75 % of these patients
were significantly improved. Hospital mortality was related
to admission diagnosis and was especially high in case of
active end-stage-cancer or hypoxiemic respiratory failure.
Hemodynamic support in oldest old patients
Evidence about hemodynamic support in the clinical set-
ting of critically ill oldest old patients with shock is based
mainly on few data because of lack of longitudinal and
randomized trials. The incidence of shock in patients older
than 80 years admitted to ICU is about 3 % [72]. Data
about incidence and outcome of cardiac shock (CS) in
oldest old patients are conflicting. Shah et al [73] showed a
high incidence of cardiogenic shock in patients aged
[85 years (33 %) with ST elevation myocardial infarction.
In these patients, the mortality rate was of 54 %. Skoinick
et al. [74] in a population of 5557 patients aged C90 years
with acute coronary syndrome showed an incidence of CS
of 3.1 versus 3.5 % of patients aged 75–89 years. The
mortality rate was of 12 %. Biston et al. [75] performed a
secondary analysis of data from a large randomized trial on
outcome of ICU patients treated with vasopressors. They
received vasopressors doses similar to the younger groups
except for dobutamine doses which were higher than the
other groups. Most of the oldest old patients were dead
after 6 (92 %) or 12 months (97 %). The two patients alive
after 1 year had no organ dysfunction except for shock
during their ICU stay; they had regained autonomy and
were still alive 3 years after the event. In the study by
Biston et al., the 26 % of patients presented cardiac
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arrhythmia and 6 % myocardial infarction. Samuels et al.
[76] demonstrate that the hospital mortality correlates with
the number and doses of inotropic support. The mortality
risk increased from 7.5 % in patients with one
inotrope/vasopressor at moderate dose to 80 % using three
inotropes at high dose. Inotropes and vasopressors,
increasing contractility and afterload, increase the
myocardial oxygen consumption. However, in oldest old
patients with shock the therapies to improve tissue perfu-
sion may be arrhythmogenic, especially in those presenting
a history of coronary artery disease [77]. Patients with
acute heart failure syndromes and end-stage heart failure
can now be stabilized emergently with the use of
mechanical circulatory support devices and extracorporeal
life support. Technologies as intra-aortic balloon counter-
pulsation (IABP), percutaneous and surgically implanted
ventricular assist devices, extracorporeal membrane oxy-
genation, and renal replacement therapies have become a
major focus of the ICU and require a multidisciplinary
approach [78]. The most important RRTs on IABP use in
acute myocardial infarction (AMI) and CS [79, 80] did not
consider the oldest old population. They considered
patients with an age[75 year, and there was no survival
benefit at 12 months of follow-up. A meta-analysis by
Sjauw et al. [81] showed that IABP increased bleeding and
stroke in AMI CS patients. Furthermore, Stretch et al. [82]
showed an increased use of short-term mechanical circu-
latory support devices in patients aged C 80 years from
6.2 % (in 2004–2007) to 11.9 % (in 2008–2011). They
found that IABP use before mechanical devices support
was a predictor of mortality and increased costs. Preoper-
ative need for IABP is a strong predictor of risk mortality
in oldest old patients undergoing surgical procedures.
Bridges et al. [83] retrospectively reviewed data of 662,033
patients from the society of thoracic surgeon national
database who underwent cardiac surgical procedures. Five
patients were more than 100 years old, 1092 patients aged
between 90 and 99 years, 59,976 patients were between 80
and 89 years and 621,360 patients were between 50 and 79.
The use of IABP, renal failure, peripheral vascular disease
and cerebrovascular disease were major risk factors for
surgical mortality. For coronary artery bypass grafting
(CABG) patients, the surgical mortality was 11.8 % for
patients aged [90 years of age, 7.1 % 80–89 years, and
2.8 % for those 50–79 years. In the past decades, the use of
Extracorporeal Membrane Oxygenation (ECMO) has
grown rapidly. Aso et al. [84] showed that patients aged
C80 years (567) treated with ECMO for CS had a mortality
rate of 81.7 %. The impella ventricular support system is a
family of percutaneous heart pumps (impella 2.5, impella
CP, impella 5.0 and impella RP). In clinical practice, the
impella catheters are used as support in patients with
hemodynamic instability. The most important trials about
impella catheters in elective and urgent high risk percuta-
neous coronary interventions (PCI), PROTECT I and II
[85, 86] excluded patients with age C 80 years. In patients
with hemodynamic instability aged C 80 years, Pershad
et al. [67] concluded that the impella circulatory support is
reasonable and feasible in selected octogenarians popula-
tion with similar outcome of younger selected patients.
Seyfarth et al. [87] published the results from ISAR-Shock
and compared the hemodynamic effects of the impella 2.5
with IABP. They showed that the impella 2.5 provided
more hemodynamic improvement compared with IABP for
cardiogenic shock patients. Further investigations are
necessary to evaluate this positive outcome in older and
oldest old patients.
Renal replacement therapy in the oldest old
patient
The epidemiology of AKI and renal replacement therapy
(RRT) in oldest old patients is still undefined because of
various clinical setting. AKI requiring RRT is a common
complication in critically ill patients. The number of very
old patients experienced acute on chronic kidney disease
(CKD) who started dialysis in the ICU as well as end-stage
renal disease (ESRD) has been grown over these past
decades. The overall incidence of AKI in ICU patients
ranges from 20 to 50 % with less incidence in elective
surgical patients and higher incidence in septic patients.
The incidence of contrast-induced AKI is less (11.5–19 %
of all admissions) than seen in the ICU population [88].
Kurella et al. [89] showed that dialysis initiation among
octogenarians and nonagenarians increased dramatically
over the past decades translating to a near doubling of the
number of patients with incident AKI aged[80 years. The
number of octogenarians and nonagenarians starting dial-
ysis increased from 7054 patients in 1996 to 13,577
patients in 2003, consisting in an average annual increase
of 9.8 %, dialysis initiation. In 2010, the United States
Renal data system report showed a high growth rate (16 %)
of dialysis in oldest old population [90]. In oldest old
patients, initiation of dialysis has a negative effect on
independent living. Jassal et al. [91] showed at the time of
dialysis the majority of patients were living at home with
no assistance for the activities of daily living. Within the
first 6 months after dialysis more than 30 % of patients had
functional loss requiring community or private-caregiver
support or transfer to nursing home. The critically ill oldest
old patients who received dialysis vasopressors and/or
mechanical ventilation had significant decline in functional
status. The 20 % of them were transferred to long-term
care facility [52]. Guerra et al. [92] found a strong asso-
ciation between the age of critically ill patients and
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subsequent diagnoses of dementia. The oldest survivors
(age[85) had a cumulative incidence of dementia of 33 %
over three years. RRT for acute renal failure was a time-
dependent risk factor that increased risks only after six
months of follow-up. The dialysis Morbidity and Mortality
Study Wave II study [93] reported the maximal prevalence
of frailty in the oldest old age patients (78.8 % of those
who were older than 80 years). The frailty was defined by
the presence of weight loss, weakness, low physical
activity and exhaustion. Tamura et al. [94] found that the
survival in patients C80 years of age, with ESRD and
starting hemodialysis was 46 % after 1 year. In this study,
the mean survival rate was of 24.9 months in patients aged
between 65 and 79 years, 15.6 % months in those aged
between 80 and 84, 11.6 months for those aged between 85
and 89 and 8.4 months in those aged 90 years and older.
Lamping et al. [95] found that 12-month survival rate of
elderly patients on dialysis was lower in patients aged over
80 years (54 %) versus patients aged between 75 and
79 years (69 %) and versus patients aged between 70 and
74 years (80 %). Despite this lower survival rate, the
authors found that comorbidity was a more important
determinant of outcome than age. Nordio et al. [96] showed
that impact of age on excess mortality risk was very rele-
vant on survival of patients treated by long-term dialysis.
Five-year relative survival showed for older patients 26
deaths/100 patient-year versus 14 deaths/100 patient-year
of patients aged between 65 and 75 years. Joly et al. [97]
analyzed the characteristics of octogenarians treated with
dialysis or conservative therapy. During the 12-year
observation period, the 68.7 % patients died. The median
survival rate was 28.9 months in patients undergoing
dialysis, compared with 8.9 months in patients treated
conservatively with substantial prolongation of life of the
patients on dialysis. In contrast with these data, Akposso
et al. colleagues [98 showed that patients older than
80 years with AKI have mortality rate similar to younger
adult patients. In patients over 80 years old, the mortality
was less severe than expected, and these patients could
benefit from the renal replacement therapy (RRT) of
modern intensive care medicine. The conventional criteria
to initiate dialysis are: dyselectrolytemia; refractory meta-
bolic acidosis, fluid overload, uremic bleeding and uremic
encephalopathy [99]. The Kidko AKI guidelines [100]
noted that patients with life-threatening indications such as
hyperkaliemia, severe acidosis or diuretic-resistant fluid
overload should be dialyzed emergently. In the absence of
these fatal events, there is a limited and controversial
evidence about the right moment to initiate RRT in criti-
cally ill patients. In this context, the Kidko guidelines
stated that there are no definitive conclusions about time of
initiation of RRT (early vs. late). However, the decision to
initiate dialysis depends on the judgment of the clinicians.
Several nonrandomized studies have reported improving
outcomes associated with earlier RRT. Bouman et al. [101]
in critically ill patients with oliguric acute renal failure
reported that survival at 28 days and recovery of renal
function were not improved by high ultrafiltration volumes
or early initiation of hemofiltration. Recently two RCTs
studied the time of initiation RRT (early vs. late RRT) with
conflicting conclusion [102, 103]. The trial ELAIN ran-
domized 231 predominantly postsurgical patients. The
median difference among those receiving RRT was 21 h.
This study included oldest old patients. Early RRT resulted
in a 15.4 % reduction in 90-day mortality compared with
delayed RRT. There was no difference in dialysis depen-
dence beyond 90 days. The AKIKI trial was a multicenter
trial that compared two strategies for starting RRT in 620
mixed critically ill patients with AKI who were receiving
mechanical ventilation and/or vasoactive drugs. The mean
age was lower than that in the ELAIN Trial. No difference
in 60-day mortality was found. For oldest old critically ill
patients, the evaluation of the time of initiation of RRT, in
daily practice, requires a multidisciplinary approach
involving the patient and relatives Although dialysis
undoubtedly prolonged survival in patients with ESRD, it
is imperative that clinicians actively discuss and consider
nonaggressive renal care in addition to RRT. Physicians
should be responsible for offering care that promotes the
best quality of life and not necessarily the longest duration
[104 Among survived critically ill patients requiring RRT,
failure to recover kidney function, progression to end-stage
kidney disease (ESKD) leading to dialysis dependence
remain a significant medical and economic issue [105]. In a
systematic review [106 intermittent renal replacement
therapy (IRRT), used as an initial modality of RRT, was
associated with a 1.7 times greater risk for dialysis
dependence when compared with continuous renal
replacement therapy (CRRT).
Cardiac arrest and cardiopulmonary resuscitation
(CPR) in oldest old patients
Cardiac arrests in adults are often due to ventricular fib-
rillation (VF) or pulseless ventricular tachycardia (VT),
which are associated with better outcomes than asystole or
pulseless electrical activity (PEA) [107]. Ventricular fib-
rillation and pulseless electrical activity were the most
common cardiac arrest rhythms in elderly patients as well
as a diagnosis of heart failure, myocardial infarction, or
renal insufficiency. In the study by Chan et al. [108], the
risk adjusted rate of 1-year survival was 63.7 % among
patients aged between 65 and 74, as compared with 58.6 %
among patients aged between 75 and 84 and 49.7 % among
patients aged 85 or older. The survival rate was
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significantly lower in oldest old population and among
patients with moderate or severe neurologic disabilities at
discharge. An epidemiologic study of in-hospital CPR in
the elderly by Ehlenbach et al. [109] analyzed 65,530
patients aged between 85 and 89 and 34,039 patients aged
90 and over. The mortality rate for the group aged between
85 and 89 was 85 % and 9895 survived to hospital dis-
charge (15.1 %). In the second group, 4156 patients
(12.2 %) survived to hospital discharge. The authors
argued that the associations of oldest old patients and
higher burden of chronic illness with poorer survival were
not surprising. The finding that residence in a skilled
nursing facility before admission provides that chronic
illness affects outcomes after CPR. The variables associ-
ated with failure to discharge in patients who undergo to
CPR were dementia, sepsis on the day before resuscitation,
increase levels of serum creatinine, cancer, coronary artery
disease and location of resuscitation [110]. Funada et al.
[111] studied the neurological outcome and survival of
large database of elderly patients with out-hospital cardiac
arrest. The cohort of oldest old patients included 136 392
patients aged between 85 and 94 and 23 577 patients aged
[95. One month survival outcome was 0.59 % (803/
132,292) among patients aged between 85 and 94 and
0.27 % (63/23,577) among patients aged[95. Compared
to patients aged between 75 and 84 those aged between 85
and 94 and [95 had significantly worse outcomes. The
authors found that annual trend in 1-month survival with
favorable neurological outcome by age, witness status, first
documented rhythm and etiology demonstrated in all sub-
groups an improvement in outcomes. Furthermore,
1-month survival with favorable outcomes did not improve
among patients in the oldest old age group or for those who
had unwitnessed out-hospital cardiac arrest. Postcardiac
arrest brain injury is a syndrome resulting from a critical
reduction in blood flow or oxygen and nutrient supply.
Common clinical features include coma and vegetative
status, seizures and myoclonus. [112]. Targeted tempera-
ture management (TTM) is an essential element of
postresuscitation care for global ischemic brain injury. The
2015 Cardiopulmonary resuscitation (CPR) guidelines
recommend that comatose (i.e. lack of meaningful response
to verbal commands) adult patients with return of sponta-
neous circulation (ROSC) have TTM (induced hypother-
mia) as a beneficial and effective treatment (class I) [113].
This guideline recommends selecting and maintaining a
constant temperature between 32 and 36 C. Data about the
use of TTM in oldest old comatose cardiac arrest survivors
seems to show that age is considered an independent pre-
dictor of TTM underutilization. A descriptive analysis of
TTM application from 130,582 completed records of the
Cardiac Arrest Registry to Enhance Survival (CARES)
found that treatment rates significantly decreased from age
75–84 [114]. Bosson et al. [115] in a retrospective study
showed that TTM was associated with improved neuro-
logic outcome in the elderly population. Busch et al. [116]
showed in advanced-age postarrest survivors group a
favorable outcome and highlight the need for more ad hoc
clinical trials.
Delirium and cognitive impairment in oldest old
seriously ill patients
Delirium is a syndrome characterized by sudden severe
confusion and rapid changes in brain function, inattention
and disorganized thinking or altered level of consciousness.
The Diagnostic and Statistical Manual of Mental disorders
4th Edition (DSM-IV) includes four items for diagnosing
delirium: disturbance of consciousness, change in cogni-
tion, development over a short period, and fluctuation
[117]. The development of delirium in older critically ill
patients is due to a dynamic and complex process associ-
ated with numerous risk factors such as advanced age,
medical comorbidity, preexisting mental impairment,
neurological diagnoses, observational and occult metabolic
abnormalities, withdrawal from chronic psychoactive
medications, sleep deprivation, sedatives [118]. Dementia
is an important predisposing risk factor during and after the
ICU recovery [119]. On the other hand, intensive care
survivors had significantly more cognitive problems than
those who did not suffer from delirium. Delirium was
considered an independent predictor of worse score on
neuropsychological testing and associated with worse
global cognition at 3 and 12 months [120, 121]. Cognitive
impairment, mainly problems with memory and names
until 18 months after discharge, seems to be correlated
with the duration of delirium during ICU recovery [122]. In
patients survived after mechanical ventilation evaluated at
12 months, the duration of delirium was associated with
worse scores on activities of daily living and impaired
perception of motor sensory function [123]. Clinical eval-
uation of delirium is difficult in the setting of unstable and
intubated patients. The incidence ranges from 19 % [124]
to 89 % [125]. A recent meta-analysis about the outcome
of delirium in critically ill patients concluded that nearly a
third of patients admitted (30 %) to an intensive care unit
develop delirium and these patients are at increased risk of
dying during admission, longer stays in hospital and cog-
nitive impairment after discharge [126]. The clinical
practice guidelines for the management of pain, agitation
and delirium in adult patients in ICU [127] stated that there
are no evidences that treatment with haloperidol reduces
the duration of delirium as opposed to atypical antipsy-
chotics. In the event of delirium unrelated to alcohol or
benzodiazepine withdrawal, this guideline suggests the
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continuous IV of dexmedetomidine rather than benzodi-
azepine infusions, and it does not recommend the admin-
istration of rivastigmine. The prevention recommends to
identify delirium risk factors (dementia, high severity ill-
ness, coma, benzodiazepine administration, ETOH abuse)
to mobilize and exercise patients early, to promote sleep, to
restart baseline psychiatric medicines if indicated and to
avoid benzodiazepine use.
Nutrition in critically oldest old patients
The impossibility to adequately feeding and anorexia for
critically ill patients in ICU could range from few days to
various months. In older patients, this context often over-
laps with preexisting malnutrition. Older people are at an
increased risk of inadequate diet and malnutrition, and the
rise in the older population will put more patients at risk.
Inadequate diet and malnutrition are associated with a
decline in functional status, impaired muscle function,
decreased bone mass, immune dysfunction, anemia,
reduced cognitive function, poor wound healing, delay in
recovering from surgery, and higher hospital and read-
mission rates and mortality [128]. In the ICU context, the
accurate evaluation of energy requirements and the
assessment of daily caloric intake to avoid undernutrition
and overfeeding are difficult. The main vital signs as for
example heart rate, respiratory rate, temperature, urine
output, fluid balance, presence of sepsis can change from
one day to another with repercussions on energy expendi-
ture. The European Society of Parenteral and Enteral
nutrition (ESPEN) guidelines [129] recommend using, as
gold standard, the indirect calorimetry (IC) but states that if
unavailable the caloric estimation could be based on body
weight or calculated with mathematical formulas. Numer-
ous studies showed that in mechanically ventilated patients
an optimal nutritional therapy is associated with a decrease
in mortality. Wells et al. [130] found a decrease in 28-day
mortality by 50 % when energy and protein targets are
reached. Increased intakes of energy and protein appear to
be associated with improved clinical outcomes in critically
ill patients, particularly when BMI is\25 or[or =35. In
oldest old critically patients, when possible, enteral nutri-
tion is mandatory for preserving intestinal function. A
meta-analysis demonstrated reduced mortality when ent-
eral nutrition was initiated early in critically ill patients
[131] as well as the late initiation of parenteral nutrition
was associated with faster recovery and fewer complica-
tions, as compared with early initiation [132]. Furthermore
clinical practice guidelines recommend enteral nutrition as
the preferred route for caloric support with early initiation
when possible [133].
Conclusion
The aging of global population requires a special attention
for the critically oldest old patients. Despite technological
advances, mortality for critically ill oldest old patients
remains high. The intensive caring should be able to
combine technology and a deep humanity considering that
the patients are living the last part of their lives. Their
clinical management should take into account the
patient’s preference and the capability to avoid the med-
ical futility respecting the patients’ quality of life and
their dying process with dignity. In selected oldest old
patients as in the case of patients with hypercapnic acute
respiratory failure or with the necessity of comfort mea-
sures only, NIMV should be preferred to IMV. Identifi-
cation of the patients at risk of malnutrition as well as of
those at risk of delirium should be the hallmark of
intensive caring. The CPR scenario requires a correct
evaluation of the possible negative outcome. Although
RRT could be safe in oldest, old is associated with high
risk of morbidity and mortality. The Italian legal issues
require further evaluations, especially about the lack of
decisional power of proxy, surrogates and relatives.
Heterogeneity of oldest old patients population need a
broader geriatric assessment and the need of the adequate
evaluation of the burden of comorbidities and critically ill
disease on prognosis. Further investigations are necessary
to develop a better therapeutic strategy for oldest old
critically ill patient-centered.
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